Skip to Main Content

Author Details

Thomas E Morrison
University of Colorado Anschutz Medical Campus
2001
101
36
PMIDPaper TitleJournal TitlePublished Year
37071849Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection.Am J Respir Cell Mol Biol2023
37961400Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2.bioRxiv2023
37591996Chikungunya virus cell-to-cell transmission is mediated by intercellular extensions in vitro and in vivo.Nat Microbiol2023
37609165Phagocyte-expressed glycosaminoglycans promote capture of alphaviruses from the blood circulation in a host species-specific manner.bioRxiv2023
37873393Chikungunya virus infection disrupts lymph node lymphatic endothelial cell composition and function via MARCO.bioRxiv2023
37159005Evidence for Aerosol Transfer of SARS-CoV-2-Specific Humoral Immunity.Immunohorizons2023
37083332Species-specific MARCO-alphavirus interactions dictate chikungunya virus viremia.Cell Rep2023
30656438Chronic Chikungunya Virus Disease.Curr Top Microbiol Immunol2022
35511797Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream.PLoS Pathog2022
35707164Harmonization of Multiple SARS-CoV-2 Reference Materials Using the WHO IS (NIBSC 20/136): Results and Implications.Front Microbiol2022
35714768Oxidative stress activates transcription of Salmonella pathogenicity island-2 genes in macrophages.J Biol Chem2022
35416719Two Conserved Phenylalanine Residues in the E1 Fusion Loop of Alphaviruses Are Essential for Viral Infectivity.J Virol2022
35618725Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease.NPJ Vaccines2022
36307168Animal models of alphavirus infection and human disease.Adv Virus Res2022
33298759Risk Factors of SARS-CoV-2 Antibodies in Arapahoe County First Responders-The COVID-19 Arapahoe SErosurveillance Study (CASES) Project.J Occup Environ Med2021
33795412Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA.J Clin Microbiol2021
33793555Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.PLoS Negl Trop Dis2021
33835811Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors.J Med Chem2021
33500361A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection.J Clin Microbiol2021
34676370Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication <i>in vitro</i>.Precis Nanomed2021
34618370MARCO<sup>+</sup> lymphatic endothelial cells sequester arthritogenic alphaviruses to limit viremia and viral dissemination.EMBO J2021
34046161Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement.Pulm Circ2021
34303688Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.J Immunol Methods2021
34152810Identification of Quinolinones as Antivirals against Venezuelan Equine Encephalitis Virus.Antimicrob Agents Chemother2021
33972373Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination.J Immunol2021
33452828Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.Transfusion2021
33361425Plasmacytoid Dendritic Cells Mediate Control of Ross River Virus Infection via a Type I Interferon-Dependent, MAVS-Independent Mechanism.J Virol2021
32348764Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross.Cell Rep2020
31999809MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2.PLoS Pathog2020
31862709Correction: Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response.J Immunol2020
31794434Chikungunya virus replication in skeletal muscle cells is required for disease development.J Clin Invest2020
32103544Introduction: Evolution of inflammatory arthritis from innate to adaptive immune mechanisms.Immunol Rev2020
32102875Chikungunya Virus Evades Antiviral CD8<sup>+</sup> T Cell Responses To Establish Persistent Infection in Joint-Associated Tissues.J Virol2020
33334435Editorial overview: At the interface: host-pathogen interactions that dictate protection and pathology.Curr Opin Immunol2020
32365139Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease.PLoS Pathog2020
32550013The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates.NPJ Vaccines2020
30909365The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya Arthritis.Viruses2019
33907560Mechanisms underlying the pathogenesis of arthritogenic alphaviruses: host immune responses and virus persistence.Future Virol2019
31736977Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease.Front Immunol2019
31615058dsRNA-Seq: Identification of Viral Infection by Purifying and Sequencing dsRNA.Viruses2019
31578287Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody.J Virol2019
31257853Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus.ACS Infect Dis2019
31596239Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses.Elife2019
30917980Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs.Antimicrob Agents Chemother2019
29263267Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway.J Virol2018
29997290Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment.JCI Insight2018
30212644Blocking the Exit: CHIKV Neutralizing Antibodies Nip Viral Egress in the Bud.Cell Host Microbe2018
30045970Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response.J Immunol2018
30372439SODB1 is essential for Leishmania major infection of macrophages and pathogenesis in mice.PLoS Negl Trop Dis2018
30301856Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.mBio2018
  • 1 - 50 of 101

Recommended Authors

James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 8
Kathleen M Voss
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2016
Number of shared co-authors 13
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 3
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 15
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 4
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 2
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
Kristin L McNally
National Institute of Allergy and Infectious Diseases
Career Start Year 2008
Number of shared co-authors 3
Colm Atkins
Rutgers University
Career Start Year 2007
Number of shared co-authors 0
Shannan L Rossi
Institute for Human Infection and Immunity, University of Texas Medical Branch
Career Start Year 2005
Number of shared co-authors 3
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 20
Cherie T Ng
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 0
Sagi Shapira
Institute for Genomic Medicine, Columbia University
Career Start Year 2002
Number of shared co-authors 0
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 3
Jean K Lim
Icahn School of Medicine at Mount Sinai
Career Start Year 1998
Number of shared co-authors 5
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 6
Gary P Kobinger
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 2
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 3
Larissa B Thackray
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 19
Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Career Start Year 1995
Number of shared co-authors 3
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 5
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 3
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 0
Chien-Te K Tseng
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 9
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 4
P Robert Beatty
School of Public Health, University of California berkeley
Career Start Year 1990
Number of shared co-authors 2
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 19
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 10
Robert F Garry
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 2

Collaborators

Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 28
Mary K McCarthy
University of Colorado School of Medicine
Co-authored papers 24
Bennett Davenport
Co-authored papers 17
Michael S Diamond
Washington University School of Medicine
Co-authored papers 9
Stephanie A Montgomery
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Co-authored papers 9
Daniel N Streblow
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 9
Alan C Whitmore
University of North Carolina at Chapel Hill
Co-authored papers 8
Victor R DeFilippis
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 7
Ross M Kedl
Co-authored papers 6
Ralph S Baric
University of North Carolina
Co-authored papers 5
Craig N Kreklywich
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 5
Bronwyn M Gunn
Co-authored papers 5
Michael Denton
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 4
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 4
Clayton R Morrison
University of North Carolina School of Medicine
Co-authored papers 2
James E Crowe
Vanderbilt University Medical Center
Co-authored papers 2
Lisa E Gralinski
University of North Carolina at Chapel Hill
Co-authored papers 2
Mehul S Suthar
Co-authored papers 2
Vineet D Menachery
University of Texas Medical Branch
Co-authored papers 2
Sarah R Leist
University of North Carolina at Chapel Hill
Co-authored papers 2
Ande West
University of North Carolina at Chapel Hill
Co-authored papers 1
Amy C Sims
The University of North Carolina at Chapel Hill
Co-authored papers 1
Robert H Carnahan
Vanderbilt University Medical Center
Co-authored papers 1
Boyd L Yount
University of North Carolina at Chapel Hill
Co-authored papers 1
Kenneth S Plante
University of Texas Medical Branch
Co-authored papers 1
William B Klimstra
Co-authored papers 1
Darla R Miller
The University of North Carolina at Chapel Hill
Co-authored papers 1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Klaus Schughart
University of Tennessee Health Science Center
Co-authored papers 1
Stuart Weston
University of Maryland School of Medicine
Co-authored papers 1
Release 1.2